Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$447K Hold
1,700
0.17% 49
2023
Q2
$387K Buy
1,700
+568
+50% +$132K 0.13% 42
2023
Q1
$271K Hold
1,132
0.11% 86
2022
Q4
$297K Hold
1,132
0.13% 47
2022
Q3
$255K Buy
1,132
+75
+7% +$18.2K 0.12% 72
2022
Q2
$257K Hold
1,057
0.15% 76
2022
Q1
$256K Sell
1,057
-7
-0.7% -$1.61K 0.11% 91
2021
Q4
$240K Hold
1,064
0.11% 90
2021
Q3
$226K Buy
+1,064
New +$245K 0.11% 87
2021
Q2
Sell
-1,139
Closed -$283K 259
2021
Q1
$283K Sell
1,139
-100
-8% -$23.9K 0.14% 70
2020
Q4
$285K Hold
1,239
0.16% 70
2020
Q3
$315K Hold
1,239
0.23% 58
2020
Q2
$292K Sell
1,239
-3
-0.2% -$684 0.23% 56
2020
Q1
$252K Buy
+1,242
New +$271K 0.31% 48
2019
Q2
Sell
-285
Closed -$55K 94
2019
Q1
$55K Sell
285
-28
-9% -$5.35K 0.05% 130
2018
Q4
$62K Buy
+313
New +$61.1K 0.08% 121

Other funds holding AMGN

PRW Wealth Management's AMGN Position: Q3 2023 in Review

PRW Wealth Management held its Amgen (AMGN) position steady in Q3 2023 at 1,700 shares worth $447K. The position accounts for 0.17% of the portfolio, ranked #49.

PRW Wealth Management first reported a position in AMGN in Q4 2018 and has held it in 16 quarters since. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • PRW Wealth Management held 1,700 shares of Amgen worth $447K as of Q3 2023.
  • PRW Wealth Management left its Amgen share count unchanged in Q3 2023.
  • Amgen made up 0.17% of PRW Wealth Management's portfolio in Q3 2023, its #49 holding.
  • PRW Wealth Management first reported a position in Amgen in Q4 2018 and has held it in 16 quarters since.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on PRW Wealth Management's 13F filing for Q3 2023, filed 1 Nov 2023.